Adial Pharmaceuticals Stock Market Value
| ADIL Stock | USD 3.12 0.31 9.04% |
| Symbol | Adial |
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adial Pharmaceuticals. If investors know Adial will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Adial Pharmaceuticals assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Adial Pharmaceuticals's market price often diverges from its book value, the accounting figure shown on Adial's balance sheet. Smart investors calculate Adial Pharmaceuticals' intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since Adial Pharmaceuticals' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Understanding that Adial Pharmaceuticals' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Adial Pharmaceuticals represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. However, Adial Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Adial Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Adial Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Adial Pharmaceuticals.
| 11/11/2025 |
| 02/09/2026 |
If you would invest 0.00 in Adial Pharmaceuticals on November 11, 2025 and sell it all today you would earn a total of 0.00 from holding Adial Pharmaceuticals or generate 0.0% return on investment in Adial Pharmaceuticals over 90 days. Adial Pharmaceuticals is related to or competes with Neurosense Therapeutics, Acurx Pharmaceuticals, Matinas BioPharma, Brainstorm Cell, Aprea Therapeutics, HCW Biologics, and Kiora Pharmaceuticals. Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for ... More
Adial Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Adial Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Adial Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.31) | |||
| Maximum Drawdown | 34.48 | |||
| Value At Risk | (8.24) | |||
| Potential Upside | 5.7 |
Adial Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Adial Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Adial Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Adial Pharmaceuticals historical prices to predict the future Adial Pharmaceuticals' volatility.| Risk Adjusted Performance | (0.23) | |||
| Jensen Alpha | (1.48) | |||
| Total Risk Alpha | (1.89) | |||
| Treynor Ratio | (1.77) |
Adial Pharmaceuticals February 9, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.23) | |||
| Market Risk Adjusted Performance | (1.76) | |||
| Mean Deviation | 3.09 | |||
| Coefficient Of Variation | (338.61) | |||
| Standard Deviation | 4.77 | |||
| Variance | 22.71 | |||
| Information Ratio | (0.31) | |||
| Jensen Alpha | (1.48) | |||
| Total Risk Alpha | (1.89) | |||
| Treynor Ratio | (1.77) | |||
| Maximum Drawdown | 34.48 | |||
| Value At Risk | (8.24) | |||
| Potential Upside | 5.7 | |||
| Skewness | (2.03) | |||
| Kurtosis | 9.99 |
Adial Pharmaceuticals Backtested Returns
Adial Pharmaceuticals secures Sharpe Ratio (or Efficiency) of -0.3, which signifies that the company had a -0.3 % return per unit of risk over the last 3 months. Adial Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Adial Pharmaceuticals' Risk Adjusted Performance of (0.23), standard deviation of 4.77, and Mean Deviation of 3.09 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.8, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Adial Pharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding Adial Pharmaceuticals is expected to be smaller as well. At this point, Adial Pharmaceuticals has a negative expected return of -1.46%. Please make sure to confirm Adial Pharmaceuticals' skewness, and the relationship between the treynor ratio and rate of daily change , to decide if Adial Pharmaceuticals performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.83 |
Very good predictability
Adial Pharmaceuticals has very good predictability. Overlapping area represents the amount of predictability between Adial Pharmaceuticals time series from 11th of November 2025 to 26th of December 2025 and 26th of December 2025 to 9th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Adial Pharmaceuticals price movement. The serial correlation of 0.83 indicates that around 83.0% of current Adial Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.83 | |
| Spearman Rank Test | 0.75 | |
| Residual Average | 0.0 | |
| Price Variance | 0.69 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out Adial Pharmaceuticals Correlation, Adial Pharmaceuticals Volatility and Adial Pharmaceuticals Performance module to complement your research on Adial Pharmaceuticals. For more information on how to buy Adial Stock please use our How to buy in Adial Stock guide.You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Adial Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.